Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis

Platelets

Volumn 28, Issue 8, 2017, Pages 799-811

  Green, Taryn N ^a   Hamilton, Justin R ^b   Morel Kopp, Marie Christine ^c,d   Zheng, Zhaohua ^b   Chen, Ting Yu T ^a   Hearn, James I ^a   Sun, Peng P ^a   Flanagan, Jack U ^a,e   Young, Deborah ^a   Barber, P Alan ^a,f   During, Matthew J ^a,g   Ward, Christopher M ^c,d   Kalev Zylinska, Maggie L ^a,h  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g OHIO STATE UNIVERSITY   (United States)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Calcium; glutamate; ion channel; platelet inhibitor; stroke

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTIBODY; AUTOANTIBODY; COLLAGEN; EPINEPHRINE; EPITOPE; GLUTAMIC ACID; GLYCINE; MONOCLONAL ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN;

ALPHA HELIX; ANTIGEN BINDING; ARTICLE; ASSAY; BLEEDING TIME; BLOOD; BLOOD CLOTTING; CONTROLLED STUDY; CRYSTAL STRUCTURE; EPITOPE MAPPING; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTE FUNCTION; THROMBOSIS; THROMBUS; ANIMAL; ANTAGONISTS AND INHIBITORS; GENETICS; METABOLISM; WISTAR RAT;

ANIMALS; AUTOANTIBODIES; BLOOD PLATELETS; HUMANS; MALE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; THROMBOSIS;

EID: 85013408539     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2017.1280149     Document Type: Article

References (52)

1. Collingridge GL, Olsen RW, Peters J, Spedding M., A nomenclature for ligand-gated ion channels. Neuropharmacology 2009;56:2–5.
2. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 2010;62:405–496.
3. Paoletti P, Bellone C, Zhou Q., NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 2013;14:383–400.
4. Hogan-Cann AD, Anderson CM., Physiological roles of non-neuronal NMDA receptors. Trends Pharmacol Sci 2016;37:750–767.
5. Almazov VA, Popov, Iu G, Gorodinskii AI, Mikhailova IA, Dambinova SA., [The sites of high affinity binding of L-[3H]glutamic acid in human platelets. A new type of platelet receptor?]. Biokhimiia 1988;53:848–852.
6. Franconi F, Miceli M, De Montis MG, Crisafi EL, Bennardini F, Tagliamonte A., NMDA receptors play an anti-aggregating role in human platelets. Thromb Haemost 1996;76:84–87.
7. Franconi F, Miceli M, Alberti L, Seghieri G, De Montis MG, Tagliamonte A., Further insights into the anti-aggregating activity of NMDA in human platelets. Br J Pharmacol 1998;124:35–40.
8. Genever PG, Wilkinson DJ, Patton AJ, Peet NM, Hong Y, Mathur A, Erusalimsky JD, Skerry TM. Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood 1999;93:2876–2883.
9. Hitchcock IS, Skerry TM, Howard MR, Genever PG., NMDA receptor-mediated regulation of human megakaryocytopoiesis. Blood 2003;102:1254–1259.
10. Kalev-Zylinska ML, Green TN, Morel-Kopp MC, Sun PP, Park YE, Lasham A, During MJ, Ward CM. N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets. Thromb Res 2014;133:837–847.
11. Wright JR, Amisten S, Goodall AH, Mahaut-Smith MP., Transcriptomic analysis of the ion channelome of human platelets and megakaryocytic cell lines. Thromb Haemost 2016;116:272–284.
12. Morrell CN, Sun H, Ikeda M, Beique JC, Swaim AM, Mason E, Martin TV, Thompson LE, Gozen O, Ampagoomian D, Sprengel R, Rothstein J, Faraday N, Huganir R, Lowenstein CJ. Glutamate mediates platelet activation through the AMPA receptor. J Exp Med 2008;205:575–584.
13. Begni B, Tremolizzo L, D’Orlando C, Bono MS, Garofolo R, Longoni M, Ferrarese C. Substrate-induced modulation of glutamate uptake in human platelets. Br J Pharmacol 2005;145:792–799.
14. Hoogland G, Bos IW, Kupper F, van Willigen G, Spierenburg HA, van Nieuwenhuizen O, de Graan PN. Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2. Neurochem Int 2005;47:499–506.
15. Tremolizzo L, DiFrancesco JC, Rodriguez-Menendez V, Sirtori E, Longoni M, Cassetti A, Bossi M, El Mestikawy S, Cavaletti G, Ferrarese C. Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation. Neurosci Lett 2006;404:262–265.
16. Castillo J, Davalos A, Naveiro J, Noya M., Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996;27:1060–1065.
17. Castillo J, Davalos A, Noya M., Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 1997;349:79–83.
18. Aliprandi A, Longoni M, Stanzani L, Tremolizzo L, Vaccaro M, Begni B, Galimberti G, Garofolo R, Ferrarese C. Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake. J Cereb Blood Flow Metab 2005;25:513–519.
19. Szydlowska K, Tymianski M., Calcium, ischemia and excitotoxicity. Cell Calcium 2010;47:122–129.
20. Forder JP, Tymianski M., Postsynaptic mechanisms of excitotoxicity: Involvement of postsynaptic density proteins, radicals, and oxidant molecules. Neuroscience 2009;158:293–300.
21. During MJ, Symes CW, Lawlor PA, Lin J, Dunning J, Fitzsimons HL, Poulsen D, Leone P, Xu R, Dicker BL, Lipski J, Young D. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000;287:1453–1460.
22. Kalev-Zylinska ML, Symes W, Little KC, Sun P, Wen D, Qiao L, Young D, During MJ, Barber PA. Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size. Stroke 2013;44:2212–2219.
23. Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M, Siren AL, Pardo LA, Sperling S, Mohd Jofrry S, Gurvich A, Jensen N, Ostmeier K, Luhder F, Probst C, Martens H, Gillis M, Saher G, Assogna F, Spalletta G, Stocker W, Schulz TF, Nave KA, Ehrenreich H. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 2014;19:1143–1149.
24. Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stocker W, Ehrenreich H. Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 2014;76:82–94.
25. Steiner J, Teegen B, Schiltz K, Bernstein HG, Stoecker W, Bogerts B., Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited. JAMA Psychiatry 2014;71:838–839.
26. Busse S, Busse M, Brix B, Probst C, Genz A, Bogerts B, Stoecker W, Steiner J. Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients. Eur Arch Psychiatry Clin Neurosci 2014;264:545–550.
27. Zerche M, Weissenborn K, Ott C, Dere E, Asif AR, Worthmann H, Hassouna I, Rentzsch K, Tryc AB, Dahm L, Steiner J, Binder L, Wiltfang J, Siren AL, Stocker W, Ehrenreich H. Preexisting serum sutoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in scute ischemic stroke. Stroke 2015;46:1180–1186.
28. Macrez R, Obiang P, Gauberti M, Roussel B, Baron A, Parcq J, Casse F, Hommet Y, Orset C, Agin V, Bezin L, Berrocoso TG, Petersen KU, Montaner J, Maubert E, Vivien D, Ali C. Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis. Stroke 2011;42:2315–2322.
29. Benchenane K, Castel H, Boulouard M, Bluthe R, Fernandez-Monreal M, Roussel BD, Lopez-Atalaya JP, Butt-Gueulle S, Agin V, Maubert E, Dantzer R, Touzani O, Dauphin F, Vivien D, Ali C. Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. J Cell Sci 2007;120:578–585.
30. Miyazaki J, Nakanishi S, Jingami H., Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1. Biochem J 1999;340(Pt 3):687–692.
31. Morel-Kopp MC, McLean L, Chen Q, Tofler GH, Tennant C, Maddison V, Ward CM. The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost 2009;7:573–581.
32. Hua VM, Abeynaike L, Glaros E, Campbell H, Pasalic L, Hogg PJ, Chen VM. Necrotic platelets provide a procoagulant surface during thrombosis. Blood 2015;126:2852–2862.
33. Kamal T, Green TN, Morel-Kopp MC, Ward CM, McGregor AL, McGlashan SR, Bohlander SK, Browett PJ, Teague L, During MJ, Skerry TM, Josefsson EC, Kalev-Zylinska ML. Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiation. Cell Signal 2015;27:1860–1872.
34. Mountford JK, Petitjean C, Putra HW, McCafferty JA, Setiabakti NM, Lee H, Tonnesen LL, McFadyen JD, Schoenwaelder SM, Eckly A, Gachet C, Ellis S, Voss AK, Dickins RA, Hamilton JR, Jackson SP. The class II PI 3-kinase, PI3KC2alpha, links platelet internal membrane structure to shear-dependent adhesive function. Nat Commun 2015;6:6535.
35. Furukawa H, Gouaux E., Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J 2003;22:2873–2885.
36. Furukawa H, Singh SK, Mancusso R, Gouaux E., Subunit arrangement and function in NMDA receptors. Nature 2005;438:185–192.
37. Mahaut-Smith MP., The unique contribution of ion channels to platelet and megakaryocyte function. J Thromb Haemost 2012;10:1722–1732.
38. Sun H, Swaim A, Herrera JE, Becker D, Becker L, Srivastava K, Thompson LE, Shero MR, Perez-Tamayo A, Suktitipat B, Mathias R, Contractor A, Faraday N, Morrell CN. Platelet kainate receptor signaling promotes thrombosis by stimulating cyclooxygenase activation. Circ Res 2009;105:595–603.
39. Zhou Y, Qiu L, Xiao Q, Wang Y, Meng X, Xu R, Wang S, Na R. Obesity and diabetes related plasma amino acid alterations. Clin Biochem 2013;46:1447–1452.
40. Varga-Szabo D, Braun A, Nieswandt B., Calcium signaling in platelets. J Thromb Haemost 2009;7:1057–1066.
41. Varga-Szabo D, Braun A, Nieswandt B., STIM and Orai in platelet function. Cell Calcium 2011;50:270–278.
42. Muik M, Frischauf I, Derler I, Fahrner M, Bergsmann J, Eder P, Schindl R, Hesch C, Polzinger B, Fritsch R, Kahr H, Madl J, Gruber H, Groschner K, Romanin C. Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J Biol Chem 2008;283:8014–8022.
43. Varga-Szabo D, Braun A, Kleinschnitz C, Bender M, Pleines I, Pham M, Renne T, Stoll G, Nieswandt B. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med 2008;205:1583–1591.
44. Braun A, Varga-Szabo D, Kleinschnitz C, Pleines I, Bender M, Austinat M, Bosl M, Stoll G, Nieswandt B. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 2009;113:2056–2063.
45. Bergmeier W, Oh-Hora M, McCarl CA, Roden RC, Bray PF, Feske S., R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 2009;113:675–678.
46. Gilio K, van Kruchten R, Braun A, Berna-Erro A, Feijge MA, Stegner D, van der Meijden PE, Kuijpers MJ, Varga-Szabo D, Heemskerk JW, Nieswandt B. Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem 2010;285:23629–23638.
47. Harper MT, Poole AW., Store-operated calcium entry and non-capacitative calcium entry have distinct roles in thrombin-induced calcium signalling in human platelets. Cell Calcium 2011;50:351–358.
48. MacKenzie AB, Mahaut-Smith MP, Sage SO., Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. J Biol Chem 1996;271:2879–2881.
49. Hassock SR, Zhu MX, Trost C, Flockerzi V, Authi KS., Expression and role of TRPC proteins in human platelets: evidence that TRPC6 forms the store-independent calcium entry channel. Blood 2002;100:2801–2811.
50. Schedel A, Thornton S, Schloss P, Kluter H, Bugert P., Human platelets express functional alpha7-nicotinic acetylcholine receptors. Arterioscler Thromb Vasc Biol 2011;31:928–934.
51. Reininger AJ., Platelet function under high shear conditions. Hamostaseologie 2009;29:21–22, 24.
52. Gleichman AJ, Spruce LA, Dalmau J, Seeholzer SH, Lynch DR., Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain. J Neurosci 2012;32:11082–11094.